US Patent Issued to GENEXINE on Nov. 25 for "Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,898, issued on Nov. 25, was assigned to GENEXINE INC. (Seongnam-si, South Korea).

"Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases" was invented by Moon Cheol Kang (Pohang-si, South Korea), Young Woo Choi (Pohang-si, South Korea), Donghoon Choi (Yongin-si, South Korea) and Young Chul Sung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobuli...